1. Home
  2. GMED vs BIO Comparison

GMED vs BIO Comparison

Compare GMED & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$87.25

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$304.68

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
BIO
Founded
2003
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
8.2B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
GMED
BIO
Price
$87.25
$304.68
Analyst Decision
Buy
Strong Buy
Analyst Count
15
4
Target Price
$92.42
$358.50
AVG Volume (30 Days)
1.3M
152.0K
Earning Date
02-19-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
358.86
N/A
EPS
3.08
N/A
Revenue
$2,769,804,000.00
$2,557,500,000.00
Revenue This Year
$16.86
$1.62
Revenue Next Year
$8.05
$2.26
P/E Ratio
$28.35
N/A
Revenue Growth
11.75
N/A
52 Week Low
$51.79
$211.43
52 Week High
$94.93
$373.69

Technical Indicators

Market Signals
Indicator
GMED
BIO
Relative Strength Index (RSI) 54.30 47.59
Support Level $87.61 $300.26
Resistance Level $88.71 $305.62
Average True Range (ATR) 1.68 6.99
MACD -0.65 0.13
Stochastic Oscillator 47.13 53.56

Price Performance

Historical Comparison
GMED
BIO

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: